11:45 am Reducing & Reversing Liver Fibrosis Using Targeted Elimination of Pathogenic Stellate Cells
Time: 11:45 am
day: Conference Day 2
Details:
- Identifying pathogenic stellate cells using advanced markers for targeting the primary drivers of liver fibrosis
- Developing antibody drug conjugate for the selective delivery of payloads directly to pathogenic stellate cells to minimize off-target effects
- Establishing the in vivo pharmacokinetic and pharmacodynamic relationship for optimizing dosing, predicting efficacy, and ensuring safety in reducing liver fibrosis
